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Abstract
Background: In the management of cutaneous melanoma, it is desirable to complete the regional
lymphadenectomy during the initial surgical procedure for wide excision of biopsy site and sentinel
lymph node (SLN) biopsy. In this study, we optimized and evaluated a rapid 17 minutes
immunostaining protocol. The discriminatory immunostaining pattern associated with the 'MCW
Melanoma Cocktail' (mixture of Melan- A, MART- 1, and tyrosinase) facilitated the feasibility of
intraoperative evaluation of imprint smears of SLNs for melanoma metastases.
Methods: Imprint smears of 51 lymph nodes from 25 cases (48 SLNs and 3 non-SLNs, 1 to 4 SLNs/
case) of cutaneous melanoma were evaluated.
Results:  Sixteen percent, 8/51 lymph nodes (28%, 7/25 cases) were positive for melanoma
metastases in immunostained permanent sections with the 'MCW melanoma cocktail'. All of these
melanoma metastases, except 1 SLN from 1 case, were also detected in rapidly immunostained
wet-fixed and air-dried smears (rehydrated in saline and postfixed in alcoholic formalin). The
cytomorphology was superior in air-dried smears, which were rehydrated in saline and postfixed
in alcoholic formalin. Wet-fixed smears frequently showed air-drying artifacts, which lead to the
focal loss of immunostaining. None of the 5 SLNs from 5 cases exhibiting capsular nevi showed a
false positive result with immunostained imprint smears.
Conclusions: Melanoma metastases can be detected intraoperatively in both air-dried smears and
wet-fixed smears immunostained with the MCW Melanoma cocktail. Air-dried smears rehydrated
in saline and postfixed in alcoholic formalin provide superior results and many practical benefits.
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Background
What is already known on this topic?
A rapid intraoperative evaluation of sentinel lymph nodes
(SLNs) for melanoma metastases during the interval
between the SLN biopsy and the wide excision of the
melanoma biopsy site may eliminate the need of an addi-
tional surgery for completion of regional
lymphadenectomy.
What this study adds?
Air-dried imprint smears which were postfixed in alco-
holic formalin following saline rehydration were optimal
for immunocytochemical evaluation with the 'MCW
melanoma cocktail'. The rapid evaluation of imprint
smears immunostained with the 'MCW melanoma cock-
tail' is reliable for the intraoperative evaluation of cutane-
ous melanoma SLNs for melanoma metastases.
The prevailing trend in the management of cutaneous
melanoma supports the sentinel lymph node (SLN)
biopsy as a standard of care [1-16], but a few authors
regard it as controversial [17,18]. In a given case where the
SLN biopsy is performed and is positive for melanoma
metastases, it is usually followed by additional surgery for
regional lymphadenectomy. A rapid intraoperative evalu-
ation of SLNs for melanoma metastases during the inter-
val between the SLN biopsy and the wide excision of the
melanoma biopsy site may eliminate the need for an addi-
tional regional lymphadenectomy surgery. Previously
evaluated approaches such as fluorodeoxyglucose-posi-
tron emission tomography [19,20], morphological evalu-
ation of frozen sections [21-24], intraoperative
morphological evaluation of imprint cytology [25,26],
and immunostaining of frozen sections [27] are not suffi-
ciently sensitive.
Imprint smears of lymph nodes can be prepared rapidly.
When compared to frozen sectioning, imprint smears are
more desirable due to lower cost, quicker process, avoid-
ance of tissue loss in the cryostat, prevention of freezing
artifact in the tissue, and the elimination of problems
associated with cryo-sectioning of fatty lymph nodes.
These advantages have resulted in a preference for imprint
smears over frozen sections by many investigators for the
evaluation of SLNs in breast carcinoma [28,29].
Although relatively specific, the morphological interpreta-
tion of imprint smears alone used for the evaluation of
melanoma metastases in SLNs is not very sensitive [25].
This is predominantly because of the inherent limitations
associated with morphological interpretation. Singly scat-
tered cells of melanoma metastases in a sea of numerous
other cells are difficult to differentiate from reactive histi-
ocytes, endothelial cells, and other cells with morphology
alone.
At the current time, frozen-section examination (with or
without immunohistochemical evaluation) and the mor-
phological evaluation of imprint cytology smears are the
methods available for intraoperative evaluation of SLN in
cutaneous melanoma. However, these studies have dem-
onstrated relatively low sensitivity and specificity, dis-
couraging the practical application [22-27].
Conventional immunomarkers such as the S-100 protein
and HMB45 suffer a significant drawback because of inter-
ference by non-melanoma cells resulting in high signal to
noise ratio [28]. Because of this, rapid and accurate intra-
operative evaluation of SLN with immunostained imprint
smears was not previously possible.
In our previous study, the 'MCW Melanoma Cocktail'- a
mixture of monoclonal antibodies- MART-1 {1:500},
Melan- A {1:100}, and Tyrosinase {1:50} (Table 1) dem-
onstrated a highly discriminatory immunostaining pat-
tern [28]. This observation suggested the feasibility of
rapid intraoperative evaluation by examining the imprint
smears of SLNs immunostained with the cocktail [28-30].
In the current study, we have optimized a protocol for the
rapid intraoperative immunostaining of SLN imprint
smears from patients with cutaneous melanoma utilizing
the 'MCW melanoma cocktail'. Our previous experience
suggested that air-dried smears postfixed in alcoholic for-
malin after saline rehydration demonstrated optimal
results for immunostaining [31]. In this study, in addition
to air-dried smears we also evaluated wet-fixed smears for
further confirmation.
Table 1: The composition of the 'MCW Melanoma Cocktail'¶
Marker Clone Source *Final Dilution in the cocktail
MART-1 M2-7C10 Signet Laboratories, Inc. Dedham, MA 1:500
Melan-A A103 Dako Corporation, Carpinteria, CA 1:100
Tyrosinase T311 Novocastra Laboratories Ltd Newcastle upon Tyne, UK 1:50
* Optimum dilution for each antibody was standardized individually for that batch of antibodies with the sections of known melanoma positive 
control. The standardized dilution was achieved as final titer in the cocktail by adding 20 µl MART-1, 100 µl Melan-A, and 200 µl Tyrosinase to 9.68 
ml of DAKO Antibody diluent (Dako Corporation, Carpinteria, CA). ¶ Adopted from Shidham et al [28].CytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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Material and methods
Patients
We prospectively studied 51 lymph nodes (48 SLNs and 3
non-SLNs) from 25 patients (range- 1–4 SLNs per patient,
mean- 2 per patient) under an IRB approved protocol at
Froedtert Memorial Lutheran Hospital / Medical College
of Wisconsin, Milwaukee, WI. A standard surgical proto-
col was used to identify the SLN [32]. The SLNs were har-
vested and submitted fresh to pathology for intraoperative
and permanent section evaluation.
Pathological evaluation of sentinel lymph nodes for melanoma metastases Figure 1
Pathological evaluation of sentinel lymph nodes for melanoma metastases. Section number 2, 5, & 8- stained with H & E; 4- 
immunostained with `MCW melanoma cocktail'; 6- negative control; 1, 3, 7, & 9- unstained. Number of slices of SLN shown 
(a,b,c) is just for illustration and would vary according to the size of the lymph node. (FPTS, formalin-fixed paraffin-embedded 
tissue sections; H & E, hematoxylin and eosin stain)
Imprint smears for intra-operative immunocytochemistry
(2 wet-fixed- 1 test and 1 negative control,
2 air-dried- 1 test and 1 negative control)
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Pathologic Examination (Figure 1)
For the evaluation of the maximum surface area of the
lymph node and most of the capsular area, the lymph
nodes were transected perpendicular to the long axis as
thin (not thicker than 2 mm) cross sections. Two pairs of
imprint smears (one test and one negative control in each
pair) were made by gently touching the cut surfaces to
glass slides without allowing the imprint to be smeared.
One of the pairs (1 test and 1 negative control) was air-
dried, rehydrated in saline, and post-fixed in 'alcoholic
formalin' [31] (see video clips as Additional file 1 Higher
resolution- (for high speed connection); or Additional file
2 Low resolution- (for low speed connection), the screen
shots in PDF file are available as Additional file 3  Screen-
shots). The other pair was wet-fixed by immersing the
imprint smears in 95% ethanol before drying. Fixed
smears were rinsed with 95% ethanol and then immunos-
tained with 'MCW melanoma cocktail' (Table 1) using a
rapid immunostaining protocol (Table 2). This rapid pro-
tocol required 17 minutes. Additional time required for
smear preparation, smear processing, and evaluation of
immunostained imprint smears may vary depending on
the number of slides controlled by some variables such as
the size and the number of SLNs submitted for evaluation.
The first imprint smears from each pair were used as a
'test' and were immunostained with the 'MCW melanoma
cocktail' by rapid protocol. The second imprint smear was
used as a 'negative control' and processed in the same
manner as the test slide except that Dako diluent® was
used in place of 'the cocktail'.
Table 2: Rapid immunostaining protocols.
Entirely manual Partially manual and with Autostainer†
1. Re-hydrate air- dried imprint smear with 0.9% saline- 15 seconds 
(slow~10 dips)
1. Re-hydrate air- dried imprint smear with 0.9% saline- 15 seconds 
(slow~10 dips)
2. Post-fix the re-hydrated smear in 'alcoholic formalin'*- 5 slow dips and 
then 1 minute
2. Post-fix the re-hydrated smear in 'alcoholic formalin'*- 5 slow dips and 
then 1 minute
3. Rinse the post-fixed smear with 95% ethanol: 5 dips 3. Rinse the post-fixed smear with 95% ethanol: 5 dips
4. Hydrate the smear in DW- 30 sec 4. 100% ethanol: 10 dips
5. 3% H2O2 in DW- 1 mt 5. 100% ethanol: 10 dips
6. Protein blocking solution- 1 mt 6. Methanol: 10 dips
7. 'MCW melanoma cocktail'**- 5 mt 7. 50%¶ H2O2inMethanol: 1 mt with agitation
8. Rinse in 0.2% Tween 20 in DW 8. Deionized water: 10 dips
9. HRP-linker Antibody***- 5 mt 9. Tris buffer (ph 7.6): 10 dips
10. Rinse in tap water 10. Place smear on Dako Autostainer which automatically applies-
11. Chromogen (DAB)- 3 mt a. Envision blocking Solution††- 1 mt
12. Rinse in tap water b. 'MCW melanoma cocktail'**- 5 mt
13. Azure B (Blue solution of Diff-Quik®)- 1 mt c. Envision+ Monoclonal HRP†††- 5 mt
14. Rinse in tap water d. Chromogen (DAB)- 3 mt
15. Harris Hematoxylin- 30 sec 11. Remove the smear(s) and proceed with the following steps
16. Rinse in tap water 12. Deionized water: 10 dips
17. Dehydrate in ascending concentration of ethanol 13. Azure B- (Blue solution of Diff-Quik®)- 1 mt
18. Clear in xylene 14. Rinse in tap water
19. Coverslip the smear with the mounting medium 15. Harris Hematoxylin- 30 sec
16. Rinse in tap water
17. Dehydrate in ascending concentration of ethanol
18. Clear in xylene
19. Coverslip the smear with the mounting medium
mt, minute; sec, seconds; DW- Distilled water *Alcohol formalin was prepared by adding 50 ml of formalin (38–40% formaldehyde) to 350 ml of 
95% ethanol and 100 ml of distilled water [modified and simplified from [31]; **'MCW melanoma cocktail'- Mixture of Melan- A, MART-1, & 
tyrosinase [28]; *** PowerVision™ Poly-AP anti-Mouse IgG (ImmunoVision Technologies, Co; Daly City, CA); †DakoAutostainer; ††Dako 
Corporation, Carpinteria, CA; †††Dako Envision+ (Dako Corporation, Carpinteria, CA); ¶ 3% 10 volume Hydrogen peroxide, USP (Hydrox 
Laboratories, Elgin, IL, USA). Positive controls were prepared from unfixed fresh melanoma tumor, which was immunoreactive for each of the 
individual components of the cocktail. The cut surface of the tumor was scraped with one end of glass slide and the scraped material accumulated 
at the end of the slide was spread between two glass slides similar to the spreading of bone marrow smears [32]. The air-dried smears were 
processed similar to 'test' slides. They were rehydrated in saline (10 to 20 seconds) and postfixed in alcoholic formalin (1 minute) [30]. The post-
fixed smears were rinsed in 95% ethanol and then dehydrated by taking the smears through absolute ethanol, cleared in xylene, and cover-slipped 
with mounting medium. The cover-slip of positive control was removed by keeping the slide in xylene overnight (for this reason a formal 
communication to pathology and immunochemistry lab at least 24 hours before the SLN surgery is required). After removing the coverslip the 
smear was passed through absolute ethanol, 95% ethanol, and then joined with the protocol for immunostaining mentioned above. These 
coverslipped smears of positive control could be archived at room temperature for long periods of time (personal experience). We have used such smears after 
removing the coverslip as positive controls up to 1 year later without loosing immunoreactivity for most of the commonly used immunomarkers.CytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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Numerous smears of positive controls (both air-dried and
wet-fixed smears) were prepared previously from a
melanoma tumor with a known immunoreactivity for
each of the three components of 'the cocktail'. These
smears were prepared by scraping the cut surface of the
fresh melanoma tumor and spreading the scraped mate-
rial between two slides as described previously [33]. The
air-dried smears were fixed in alcoholic formalin after
saline rehydration. Both smears (air-dried, saline rehy-
drated smears, post-fixed in alcoholic formalin and wet-
smears fixed in 95% ethanol) were stored after processing
them through ascending grades of alcohol and xylene, fol-
lowed by mounting with a glass coverslip using mounting
medium (Table 2).
Both air-dried and wet-fixed positive control smears were
used during immunostaining for each batch of test smears
by removing the coverslip following immersion of the
slide in xylene for about 24 hours. This dissolves the
mounting medium and separates the coverslip. After
removal of the coverslip, the smears were put through
absolute ethanol and then descending grades of ethanol
to water to be combined with the respective step in the
rapid immunostaining protocol (Table 2).
The immunostained imprint smears were evaluated for
melanoma micrometastases. The test smears were com-
pared with corresponding positive controls (air-dried ver-
sus wet-fixed). The wet-fixed test smear from a given SLN
was compared with a respective air-dried test smear by
evaluating the sharpness of immunostaining, morpholog-
ical details of the immunostained tumor cells, frequency
of staining of non-melanoma structures such as mast cells
and erythrocytes, air-drying artifact, deterioration in the
immunostaining of the cells with unequivocal features of
tumor cells, and nonspecific background staining. The
results were interpreted by pathologists as positive, inde-
terminate, or negative for melanoma metastases. For sta-
tistical analysis, indeterminate interpretations of
immunostained imprint smears were considered negative.
This was based on the clinical significance with reference
to the intraoperative decision algorithm for the comple-
tion of regional lymphadenectomies in SLN positive
cases.
After the preparation of imprint smears, the slices of SLNs
were fixed in 10% formalin and processed for formalin-
fixed paraffin-embedded tissue sectioning. These sections
were evaluated according to the melanoma protocol (Fig-
ure 1) and immunostained by the avidin-biotin-peroxi-
dase complex (ABC) method described previously [28].
Results
Wet-fixed smears were difficult to prepare without focal
air-drying artifact (Figure 2, Table 3). This difficulty was
due to the time required to transfer each of the SLN slices
on the glass slide one by one and then immersing the slide
(with some of the imprints already dried) in 95% ethanol
for wet fixation. This was not a concern while preparing
the air-dried smears, as all the imprints were ultimately
dried before processing (see Additional files 1,2,&1). The
turnaround time for processing, immunostaining, and
evaluating the smears was approximately 28 (range, 24–
37) minutes.
The immunostained tumor cells of melanoma metastases
demonstrated a high nuclear/cytoplasmic ratio. The
immunostaining was non-granular and cytoplasmic. The
cytoplasmic immunostaining pattern facilitated the
evaluation of the nuclear details. The cell margins were
usually well defined. Unlike the chromatin of mast cells,
the nuclear chromatin was not clumped and did not
resemble the chromatin of the lymphocytes in the back-
ground. Nucleoli were usually prominent (Figure 3).
Because of the brief peroxidase blocking step, the endog-
enous peroxidase could not be blocked entirely in some
cases, leading to the staining of some non-melanoma cells
such as mast cells. These were detectable in both test
smears and negative control smears. The mast cells
showed smaller round nuclei with clumped chromatin.
This clumped chromatin was comparable to the nuclear
chromatin of adjacent lymphocytes in the background.
The staining was coarsely granular. The cell margins of
mast cells were usually hazy and ill-defined (Figure 4).
Rarely some nuclei demonstrated brown staining (the
cocktail immunostaining is cytoplasmic and is not
nuclear). The cells with such brown stained nuclei were
morphologically consistent with histiocytes (Figure 4f
&4g). Unequivocal nuclear staining without cytoplasmic
immunostaining should be interpreted as negative in
immunostained imprint smears. Brown non-nucleated
round to irregular material (probably erythrocytes with
unblocked endogenous peroxidase) was observed in a few
cases (Figure 4h).
The non-specific staining was relatively frequent in wet-
fixed smears (versus alcoholic formalin fixed saline rehy-
drated air-dried smears) and in manually immunostained
smears (versus smears immunostained with Autostainer).
These structures were usually interpreted as negative with
ease. However, this factor could increase the interpreta-
tion time for negative cases due to the distraction effect
and could prolong the crucial turn around time for intra-
operative consultation.
Seventeen percent (8 out of 48) lymph nodes (28%, 7/25
cases) were positive for melanoma metastases in
immunostained permanent sections. All melanomaCytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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Comparison of cytomorphological features of immunostained, air-dried smears postfixed in alcoholic formalin after saline rehy- dration (ADS, 'a') versus wet-fixed smears fixed in 95% ethanol (WFS, 'b' through 'd') Figure 2
Comparison of cytomorphological features of immunostained, air-dried smears postfixed in alcoholic formalin after saline rehy-
dration (ADS, 'a') versus wet-fixed smears fixed in 95% ethanol (WFS, 'b' through 'd'). The cytoplasmic immunostaining for the 
'MCW melanoma cocktail' does not obscure the nuclei in 'a'. In contrast, immunostaining of shrunken cytoplasm around nuclei 
in wet-fixed smears obscures the nuclear details (arrows in 'b'). Air-drying artifact is present focally (arrows in 'c') with the 
presence of non-specific background staining (arrows in 'd').
Table 3: Comparison of air-dried versus wet-fixed imprint smears.
S.No. Feature Air-dried imprint smears Wet-fixed imprint smears
1 Ease of preparing imprint smears of SLNs Easy Challenging
2 Air-drying artifact Not applicable Frequent
3 Non-specific background staining Rare Frequent
4 Immunostaining of non-melanoma structures Rare Common
5 Ease of processing, handling, and transporting the smears Easy Difficult
6 Loss of immunoreactivity of melanoma tumor cells due to air-drying 
artifact
Not applicable Possible with potential for 
false negativity.
7 Sharpness of immunostaining Present Present
8 Shrinkage artifacts Absent Frequent
9 Morphological details of immunostained smears Good Poor
10 Potential loss of sample material on slide during immersion of slide in the 
fixative
Rare Frequent
ADS 40X WFS 40X
WFS 100X WFS 100X
a a b a
c dCytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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metastases, except 1 SLN from 1 case, were demonstrated
in both wet-fixed and air-dried imprint smears immunos-
tained with the rapid protocol (sensitivity 89% and
specificity 100%). On a case by case basis, 86% (6/7) of
positive cases showed metastases in imprint smears
immunostained with the 'MCW melanoma cocktail'; and
demonstrated a sensitivity of 86%, a specificity of 100%,
a negative predictive value of 95%, and a positive predic-
tive value of 100%.
Imprint smears, immunostained with the rapid protocol,
showed unequivocal melanoma metastases in 1 SLN
which was negative by immunohistochemical evaluation
of permanent sections. This was one of the SLN from a
case with two other unequivocally positive SLNs in per-
manent sections and rapid immunostained imprint
smears. This unequivocal positivity with immunostained
imprint smears alone underscored the sampling benefit
with imprint cytology.
Two SLNs (from 2 patients) interpreted as negative for
melanoma metastases by immunohistochemical evalua-
tion of permanent sections, were interpreted as
indeterminate with the rapid protocol in both wet-fixed
and air-dried smears. After retrospective evaluation, the
rare doubtful cells observed in immunostained imprint
smears were consistent with mast cells (Figure 4 a through
4e).
In 2 SLNs from 2 other cases, some scattered cells with
non-granular immunostaining but with small, inconspic-
uous nuclei were observed. These cells were not mast cells
and were absent in negative controls. They were also
present as scattered single cells in permanent sections
Cytomorphological spectrum of tumor cells (arrows) of melanoma metastases from different cases in rapidly immunostained  air-dried imprint smears with the 'MCW melanoma cocktail' after saline rehydration and postfixation in alcoholic formalin Figure 3
Cytomorphological spectrum of tumor cells (arrows) of melanoma metastases from different cases in rapidly immunostained 
air-dried imprint smears with the 'MCW melanoma cocktail' after saline rehydration and postfixation in alcoholic formalin. The 
tumor cells are large with well defined borders and show high nuclear to cytoplasmic ratio with non-granular cytoplasmic stain-
ing with clear nuclear details. The nuclear chromatin does not resemble the chromatin of adjacent lymphocytes in the 
background.
100X 100X 40X
100X 100X 40X
100X
100XCytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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immunostained with 'the cocktail'. They were interpreted
as benign and negative.
Discussion
Metastases of melanoma tumor cells in SLN could be
detected in imprint smears immunostained with the
'MCW melanoma cocktail'. The air-dried imprint smears
from different SLNs were easier to prepare than wet-fixed
smears. As reported previously, air-dried smears have
numerous advantages [34]. Because of the shrinkage fac-
tor associated with wet-fixation, the cellular details are
less distinct in wet-fixed smear as compared to air-dried
smears. The wet-fixed smears frequently showed non-spe-
cific background staining. They also showed air-drying
artifact, which frequently compromised the immunoreac-
tivity, resulting in multifocal faint or false negative immu-
nostaining (Table 3). Wet-fixed smears with a scant
number of tumor cells may be translated into a false neg-
ative result because of air-drying artifacts.
Imprint smears (both air-dried and wet-fixed) immunos-
tained with the 'MCW melanoma cocktail' showed
excellent sensitivity and specificity (the indeterminate
interpretations were equivalent to negative results). As
compared to this, the alternative intraoperative
approaches such as frozen-section alone [22],
immunostaining of frozen sections with a cocktail of
Melan- A, HMB-45, & tyrosinase [27], and the morpho-
logical evaluation of imprint smears alone [25,35] dem-
onstrated relatively poor results. This is of practical
Morphological spectrum of non-tumor structures in rapidly immunostained air-dried imprint smears with 'MCW melanoma cock- tail' after saline rehydration and postfixation in alcoholic formalin Figure 4
Morphological spectrum of non-tumor structures in rapidly immunostained air-dried imprint smears with 'MCW melanoma cock-
tail' after saline rehydration and postfixation in alcoholic formalin. a through e: Mast cells (brown arrows) show low nuclear/
cytoplasmic ratio with granular staining of cytoplasm and fuzzy cell borders. The nuclear chromatin is clumped and resembled 
the chromatin of lymphocytes in the background. f: Non-nucleated ill defined structures (black arrow). g & h: Cells with immu-
noreactive nucleus (blue arrow). Insets of both g & h- zoomed cells with unequivocally negative cytoplasm but with brown 
staining of nucleus.
100X 100X 20X
100X 100X 100X
100X
b c d
g f e h
100X
aCytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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significance. It facilitates the intraoperative decision to
proceed with regional lymphadenectomy during the same
anesthetic procedure.
Immunostained imprint smears unequivocally showed
melanoma metastases in one SLN, but these melanoma
metastases were not detected in permanent sections
immunostained with 'the cocktail'. Two other SLNs from
this case showed melanoma metastases in both immunos-
tained permanent sections and imprint smears. This une-
quivocally positive result with immunostained imprint
smears highlights the benefit of the enhanced sampling
with imprint cytology.
Imprint smearing facilitates the sampling of two surfaces
from each slice, except for the first and the last slice, as
compared to only one surface of all slices by any section-
ing method (Figure 1). In contrast to a sectioning method
yielding 3–4 micron sections, which represent a tiny frac-
tion of the lymph node slice, immunostained imprint
smears facilitate the evaluation of the entire material sam-
pled as an imprint on the glass slide from the cut surface
of the lymph node.
The possibility of false positive results due to the cells of
capsular nevi was disproved by the negativity of all immu-
nostained imprint smears from 5 SLNs (5 cases) with
capsular nevi. The cells in capsular melanocytic nevi
located in the capsule and fibrous septa of lymph node
did not exfoliate and adhere to slides during preparation
of imprint smears. This appears to be due to the greater
cohesiveness of the cells in capsular melanocytic nevi than
the cells of malignant melanoma.
However, scattered cells with non-granular cytoplasmic
brown staining which masked the small and inconspicu-
ous nucleus were observed in 2 SLN of 2 cases. Such cells
exhibiting benign morphology were also observed as scat-
tered single cells in permanent sections immunostained
with 'the cocktail'. These cells were interpreted as negative
without significant challenge, but their exact nature could
not be established. The possibility of singly scattered
nevus cells was considered. Contrary to capsular nevus
cells, such cells may be detached easily and picked up by
the glass slide during the preparation of imprint smears.
In some cases, they may cause an interpretation dilemma
leading to indeterminate results even with permanent
sections.
In 2 patients, 2 SLNs were interpreted as indeterminate
with immunostained imprint smears. They were inter-
preted as negative by the immunohistochemical evalua-
tion of permanent sections. Cytomorphologically, the
rare doubtful cells present in immunostained imprint
smears were consistent with mast cells. They were also
present in the respective negative controls (Figure 4).
As endogenous peroxidase activity could not be blocked
completely during the short endogenous peroxidase
blocking step in the rapid protocol, non-melanoma cells
such as mast cells may show brown staining in some
cases. Familiarity with the morphological spectrum of
immunostained tumor cells (Figure 3) and other non-spe-
cifically stained cells including mast cells (Figure 4) in
immunostained imprint smears should prevent the inde-
terminate interpretation of these cells in future.
The positive control smears may be prepared from time to
time utilizing fresh, unfixed melanoma tumors for long
term availability. Alternatively, the smears of melanoma
tumor cell lines immunoreactive to individual compo-
nents of the cocktail may be used after processing and
fixing similar to test smears. These smears may be dehy-
drated and coverslipped (Table 2). Coverslipped positive
control smears could be archived at room temperature for
extended time periods. Coverslips can be removed by
immersing the slides in xylene (usually 24 hours) to dis-
solve the mounting medium and to loosen the glass cov-
erslip from the slide. We have used such smears after
removing the coverslip as positive controls up to 1 year
after they were originally prepared without affecting
immunoreactivity for most of the commonly used immu-
nomarkers including the 'MCW melanoma cocktail' (per-
sonal experience). Since a positive control had to be
processed in advance by removing the coverslip in xylene,
a notice at least one day prior to the intraoperative evalu-
ation was required routinely as a part of the protocol.
Imprint smears are easy and quick to make without incur-
ring significant expense. They are faster than frozen sec-
tioning and help prevent the loss of tissue associated with
cryosectioning. Frozen-sectioning of lymph nodes is fre-
quently problematic because of fat, either adjacent to or in
the lymph node. These problems are circumvented with
imprint smears, which would also prevent problems asso-
ciated with the interpretation of final permanent sections
of frozen tissue.
For billing and reimbursement purpose, the rapid intra-
operative evaluation of immunostained imprint smears
may be coded with existing CPT (Current Procedural Ter-
minology) codes- 88329 for the intraoperative consulta-
tion, 88161 for the preparation and processing of the
imprint smears, and 88342 for the immunostaining of the
imprint smears with interpretation [36].
As a future prospect, a 'cocktail' of directly conjugated
individual antibodies (with a peroxidase or similar indica-
tor system) used for a one step immunostaining methodCytoJournal 2004, 1:2 http://www.cytojournal.com/content/1/1/2
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resulting in a significant reduction in immunostaining
time (up to 6 minutes) with fewer staining steps would
simplify the procedure [37]. As discussed above, the rapid
protocol may not block the endogenous peroxidase.
Rapid blocking of endogenous peroxidase with specific
inhibitors / blocking agents, without affecting the cyto-
morphology, could prevent the non-specific staining of
mast cells. This would improve the interpretation speed
and confidence by eliminating the distraction factor of
non-specifically stained cells thus reducing the chances of
indeterminate interpretations and simplify the learning
curve.
In summary, air-dried imprint smears which were post-
fixed in alcoholic formalin following saline rehydration
were optimal for immunocytochemical evaluation with
the 'MCW melanoma cocktail'. Wet-fixed smears did not
compromise the immunoreactivity of 'the cocktail', but
they were difficult to prepare without air drying artifact
and non-specific background staining. Capsular melano-
cytic nevi did not show false positive results. The rapid
evaluation of imprint smears immunostained with the
'MCW melanoma cocktail' is reliable for the intraopera-
tive evaluation of cutaneous melanoma SLNs for
melanoma metastases.
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